001     127641
005     20240228135031.0
024 7 _ |a 10.1016/j.ccr.2014.02.004
|2 doi
024 7 _ |a pmid:24651015
|2 pmid
024 7 _ |a pmc:PMC4493053
|2 pmc
024 7 _ |a 1535-6108
|2 ISSN
024 7 _ |a 1878-3686
|2 ISSN
024 7 _ |a altmetric:2191713
|2 altmetric
037 _ _ |a DKFZ-2017-03664
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Kool, Marcel
|0 P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8
|b 0
|e First author
|u dkfz
245 _ _ |a Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.
260 _ _ |a Cambridge, Mass.
|c 2014
|b Cell Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1506586959_13889
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Smoothened (SMO) inhibitors recently entered clinical trials for sonic-hedgehog-driven medulloblastoma (SHH-MB). Clinical response is highly variable. To understand the mechanism(s) of primary resistance and identify pathways cooperating with aberrant SHH signaling, we sequenced and profiled a large cohort of SHH-MBs (n = 133). SHH pathway mutations involved PTCH1 (across all age groups), SUFU (infants, including germline), and SMO (adults). Children >3 years old harbored an excess of downstream MYCN and GLI2 amplifications and frequent TP53 mutations, often in the germline, all of which were rare in infants and adults. Functional assays in different SHH-MB xenograft models demonstrated that SHH-MBs harboring a PTCH1 mutation were responsive to SMO inhibition, whereas tumors harboring an SUFU mutation or MYCN amplification were primarily resistant.
536 _ _ |a 312 - Functional and structural genomics (POF3-312)
|0 G:(DE-HGF)POF3-312
|c POF3-312
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Biphenyl Compounds
|2 NLM Chemicals
650 _ 7 |a GLI2 protein, human
|2 NLM Chemicals
650 _ 7 |a Hedgehog Proteins
|2 NLM Chemicals
650 _ 7 |a Kruppel-Like Transcription Factors
|2 NLM Chemicals
650 _ 7 |a LDE225
|2 NLM Chemicals
650 _ 7 |a MYCN protein, human
|2 NLM Chemicals
650 _ 7 |a N-Myc Proto-Oncogene Protein
|2 NLM Chemicals
650 _ 7 |a Nuclear Proteins
|2 NLM Chemicals
650 _ 7 |a Oncogene Proteins
|2 NLM Chemicals
650 _ 7 |a PTCH protein, human
|2 NLM Chemicals
650 _ 7 |a Patched Receptors
|2 NLM Chemicals
650 _ 7 |a Patched-1 Receptor
|2 NLM Chemicals
650 _ 7 |a Ptch1 protein, mouse
|2 NLM Chemicals
650 _ 7 |a Pyridines
|2 NLM Chemicals
650 _ 7 |a Receptors, Cell Surface
|2 NLM Chemicals
650 _ 7 |a Receptors, G-Protein-Coupled
|2 NLM Chemicals
650 _ 7 |a Repressor Proteins
|2 NLM Chemicals
650 _ 7 |a SHH protein, human
|2 NLM Chemicals
650 _ 7 |a SMO protein, human
|2 NLM Chemicals
650 _ 7 |a SUFU protein, human
|2 NLM Chemicals
650 _ 7 |a Smoothened Receptor
|2 NLM Chemicals
650 _ 7 |a TP53 protein, human
|2 NLM Chemicals
650 _ 7 |a Tumor Suppressor Protein p53
|2 NLM Chemicals
650 _ 7 |a Phosphatidylinositol 3-Kinases
|0 EC 2.7.1.-
|2 NLM Chemicals
650 _ 7 |a Proto-Oncogene Proteins c-akt
|0 EC 2.7.11.1
|2 NLM Chemicals
650 _ 7 |a TERT protein, human
|0 EC 2.7.7.49
|2 NLM Chemicals
650 _ 7 |a Telomerase
|0 EC 2.7.7.49
|2 NLM Chemicals
650 _ 7 |a DDX3X protein, human
|0 EC 3.6.1.-
|2 NLM Chemicals
650 _ 7 |a DEAD-box RNA Helicases
|0 EC 3.6.4.13
|2 NLM Chemicals
700 1 _ |a Jones, David
|0 P:(DE-He78)551bb92841f634070997aa168d818492
|b 1
|u dkfz
700 1 _ |a Jäger, Natalie
|0 P:(DE-He78)bff9e3e3d86865d2b0836bb8f3ce98f3
|b 2
|u dkfz
700 1 _ |a Northcott, Paul A
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Pugh, Trevor J
|b 4
700 1 _ |a Hovestadt, Volker
|0 P:(DE-He78)744146d3b5a3df1e0ac555e5bf1ee5cc
|b 5
|u dkfz
700 1 _ |a Piro, Rosario M
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Esparza, L Adriana
|b 7
700 1 _ |a Markant, Shirley L
|b 8
700 1 _ |a Remke, Marc
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Milde, Till
|0 P:(DE-HGF)0
|b 10
700 1 _ |a Bourdeaut, Franck
|b 11
700 1 _ |a Ryzhova, Marina
|b 12
700 1 _ |a Sturm, Dominik
|0 P:(DE-He78)a46a5b2a871859c8e2d63d2f8c666807
|b 13
|u dkfz
700 1 _ |a Pfaff, Elke
|0 P:(DE-He78)c0538fae462bd98e3cd8d54ed885b0eb
|b 14
|u dkfz
700 1 _ |a Stark, Sebastian
|0 P:(DE-He78)75cc815aba77c01af41fe20138617e9c
|b 15
|u dkfz
700 1 _ |a Hutter, Sonja
|0 P:(DE-He78)81d14a5d74f69c16e5e1cd0144cd955c
|b 16
|u dkfz
700 1 _ |a Seker-Cin, Huriye
|0 P:(DE-HGF)0
|b 17
700 1 _ |a Johann, Pascal
|0 P:(DE-He78)3fdc3623477264cb5d0e14f256dbfbb8
|b 18
|u dkfz
700 1 _ |a Bender, Sebastian
|0 P:(DE-HGF)0
|b 19
700 1 _ |a Schmidt, Christin
|0 P:(DE-He78)fe53b38061056c5d390f37ce8d63f505
|b 20
|u dkfz
700 1 _ |a Rausch, Tobias
|b 21
700 1 _ |a Shih, David
|b 22
700 1 _ |a Reimand, Jüri
|b 23
700 1 _ |a Sieber, Laura
|0 P:(DE-He78)a4101d4d75f0b7d1f24f67ccbe63164b
|b 24
|u dkfz
700 1 _ |a Wittmann, Andrea
|0 P:(DE-He78)adf0bc22f6c87d09ddb939645a7870ed
|b 25
|u dkfz
700 1 _ |a Linke, Linda
|0 P:(DE-He78)6d11868e38db68de03387dc1a12afcdc
|b 26
|u dkfz
700 1 _ |a Witt, Hendrik
|0 P:(DE-He78)046fd145f1008f83f6236580727bbc0f
|b 27
|u dkfz
700 1 _ |a Weber, Ursula
|0 P:(DE-He78)4fbd3823a23414f37b9f1a445cad566e
|b 28
|u dkfz
700 1 _ |a Zapatka, Marc
|0 P:(DE-He78)1beba8f953e7ae7e96e8d3e9a48f10f7
|b 29
|u dkfz
700 1 _ |a König, Rainer
|0 P:(DE-He78)4291b9a1fa95bfd7a810372e2d629c32
|b 30
|u dkfz
700 1 _ |a Beroukhim, Rameen
|b 31
700 1 _ |a Bergthold, Guillaume
|b 32
700 1 _ |a van Sluis, Peter
|b 33
700 1 _ |a Volckmann, Richard
|b 34
700 1 _ |a Koster, Jan
|b 35
700 1 _ |a Versteeg, Rogier
|b 36
700 1 _ |a Schmidt, Sabine
|0 P:(DE-He78)d6e2a991c1003a27b302b66a5477e6cd
|b 37
|u dkfz
700 1 _ |a Wolf, Stephan
|0 P:(DE-He78)1efb774993effe7a66a6ffc1b1cf9ccb
|b 38
|u dkfz
700 1 _ |a Lawerenz, Christian
|0 P:(DE-He78)5398550c21bc4ce3b0ff670b04150334
|b 39
|u dkfz
700 1 _ |a Bartholomae, Cynthia C
|0 P:(DE-HGF)0
|b 40
700 1 _ |a von Kalle, Christof
|0 P:(DE-He78)5bacb661d5d7c0220d8f996d980ad8de
|b 41
|u dkfz
700 1 _ |a Unterberg, Andreas
|b 42
700 1 _ |a Herold-Mende, Christel
|0 P:(DE-HGF)0
|b 43
700 1 _ |a Hofer, Silvia
|b 44
700 1 _ |a Kulozik, Andreas E
|b 45
700 1 _ |a von Deimling, Andreas
|0 P:(DE-He78)a8a10626a848d31e70cfd96a133cc144
|b 46
|u dkfz
700 1 _ |a Scheurlen, Wolfram
|b 47
700 1 _ |a Felsberg, Jörg
|b 48
700 1 _ |a Reifenberger, Guido
|b 49
700 1 _ |a Hasselblatt, Martin
|b 50
700 1 _ |a Crawford, John R
|b 51
700 1 _ |a Grant, Gerald A
|b 52
700 1 _ |a Jabado, Nada
|b 53
700 1 _ |a Perry, Arie
|b 54
700 1 _ |a Cowdrey, Cynthia
|b 55
700 1 _ |a Croul, Sydney
|b 56
700 1 _ |a Zadeh, Gelareh
|b 57
700 1 _ |a Korbel, Jan O
|b 58
700 1 _ |a Doz, Francois
|b 59
700 1 _ |a Delattre, Olivier
|b 60
700 1 _ |a Bader, Gary D
|b 61
700 1 _ |a McCabe, Martin G
|b 62
700 1 _ |a Collins, V Peter
|b 63
700 1 _ |a Kieran, Mark W
|b 64
700 1 _ |a Cho, Yoon-Jae
|b 65
700 1 _ |a Pomeroy, Scott L
|b 66
700 1 _ |a Witt, Olaf
|0 P:(DE-He78)143af26de9d57bf624771616318aaf7c
|b 67
|u dkfz
700 1 _ |a Brors, Benedikt
|0 P:(DE-He78)fc949170377b58098e46141d95c72661
|b 68
|u dkfz
700 1 _ |a Taylor, Michael D
|b 69
700 1 _ |a Schüller, Ulrich
|b 70
700 1 _ |a Korshunov, Andrey
|0 P:(DE-He78)8d9c904a6cea14d4c99c78ba46e41f93
|b 71
|u dkfz
700 1 _ |a Eils, Roland
|0 P:(DE-He78)78b6aa82148e60b4d91e3a37a6d3d9a0
|b 72
|u dkfz
700 1 _ |a Wechsler-Reya, Robert J
|b 73
700 1 _ |a Lichter, Peter
|0 P:(DE-He78)e13b4363c5fe858044ef8a39c02c870c
|b 74
|e Last author
|u dkfz
700 1 _ |a Pfister, Stefan
|0 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
|b 75
|e Last author
|u dkfz
700 1 _ |a Project, ICGC PedBrain Tumor
|b 76
|e Collaboration Author
773 _ _ |a 10.1016/j.ccr.2014.02.004
|g Vol. 25, no. 3, p. 393 - 405
|0 PERI:(DE-600)2074034-7
|n 3
|p 393 - 405
|t Cancer cell
|v 25
|y 2014
|x 1535-6108
909 C O |o oai:inrepo02.dkfz.de:127641
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)551bb92841f634070997aa168d818492
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)bff9e3e3d86865d2b0836bb8f3ce98f3
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)744146d3b5a3df1e0ac555e5bf1ee5cc
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)a46a5b2a871859c8e2d63d2f8c666807
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-He78)c0538fae462bd98e3cd8d54ed885b0eb
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 15
|6 P:(DE-He78)75cc815aba77c01af41fe20138617e9c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 16
|6 P:(DE-He78)81d14a5d74f69c16e5e1cd0144cd955c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 17
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 18
|6 P:(DE-He78)3fdc3623477264cb5d0e14f256dbfbb8
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 19
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 20
|6 P:(DE-He78)fe53b38061056c5d390f37ce8d63f505
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 24
|6 P:(DE-He78)a4101d4d75f0b7d1f24f67ccbe63164b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 25
|6 P:(DE-He78)adf0bc22f6c87d09ddb939645a7870ed
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 26
|6 P:(DE-He78)6d11868e38db68de03387dc1a12afcdc
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 27
|6 P:(DE-He78)046fd145f1008f83f6236580727bbc0f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 28
|6 P:(DE-He78)4fbd3823a23414f37b9f1a445cad566e
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 29
|6 P:(DE-He78)1beba8f953e7ae7e96e8d3e9a48f10f7
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 30
|6 P:(DE-He78)4291b9a1fa95bfd7a810372e2d629c32
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 37
|6 P:(DE-He78)d6e2a991c1003a27b302b66a5477e6cd
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 38
|6 P:(DE-He78)1efb774993effe7a66a6ffc1b1cf9ccb
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 39
|6 P:(DE-He78)5398550c21bc4ce3b0ff670b04150334
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 40
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 41
|6 P:(DE-He78)5bacb661d5d7c0220d8f996d980ad8de
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 46
|6 P:(DE-He78)a8a10626a848d31e70cfd96a133cc144
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 67
|6 P:(DE-He78)143af26de9d57bf624771616318aaf7c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 68
|6 P:(DE-He78)fc949170377b58098e46141d95c72661
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 71
|6 P:(DE-He78)8d9c904a6cea14d4c99c78ba46e41f93
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 72
|6 P:(DE-He78)78b6aa82148e60b4d91e3a37a6d3d9a0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 74
|6 P:(DE-He78)e13b4363c5fe858044ef8a39c02c870c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 75
|6 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-312
|2 G:(DE-HGF)POF3-300
|v Functional and structural genomics
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2014
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER CELL : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 20
|0 StatID:(DE-HGF)9920
|2 StatID
|b CANCER CELL : 2015
920 1 _ |0 I:(DE-He78)B062-20160331
|k B062
|l Pädiatrische Neuroonkologie
|x 0
920 1 _ |0 I:(DE-He78)B080-20160331
|k B080
|l Theoretische Bioinformatik
|x 1
920 1 _ |0 I:(DE-He78)B060-20160331
|k B060
|l Molekulare Genetik
|x 2
920 1 _ |0 I:(DE-He78)G100-20160331
|k G100
|l Translationale Onkologie
|x 3
920 1 _ |0 I:(DE-He78)G380-20160331
|k G380
|l KKE Neuropathologie
|x 4
920 1 _ |0 I:(DE-He78)G340-20160331
|k G340
|l KKE Pädiatrische Onkologie
|x 5
920 1 _ |0 I:(DE-He78)W190-20160331
|k W190
|l Hochdurchsatz-Sequenzierung
|x 6
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B062-20160331
980 _ _ |a I:(DE-He78)B080-20160331
980 _ _ |a I:(DE-He78)B060-20160331
980 _ _ |a I:(DE-He78)G100-20160331
980 _ _ |a I:(DE-He78)G380-20160331
980 _ _ |a I:(DE-He78)G340-20160331
980 _ _ |a I:(DE-He78)W190-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21